Get Antiretroviral Pregnancy Registry - Glaxosmithkline Pregnancy ...

The Mepolizumab Pregnancy Exposure Study is a prospective, observational, exposure cohort study of pregnancy outcomes in women exposed to mepolizumab during pregnancy compared to pregnancy outcomes in women who have not used mepolizumab during pregnancy but have used other anti-asthmatic medications (treated disease ...

From the FDA Office of Women's Health Pregnancy exposure registries are research studies that collect information about the effect that prescription medicines taken or vaccines received during pregnancy may have on you and your developing fetus.

Pregnancy Registry Objectives Many exposure registries have as their primary objective to “assess the risk of major congenital malformations” in the offspring of women exposed to a given drug just before or during pregnancy. Implicit in this objective is to determine whether that risk is higher or lower than expected.

The Acyclovir Pregnancy Registry, established in 1984, and Pregnancy Registry, established in 1995, were completed in 1999. A final study is available to interested healthcare providers by calling the GlaxoSmithKline Customer Response Center at 1-888-825-5249 (toll-free).

Pregnancy exposure registries are research studies that collect health information on exposure to medical products such as medicines (drugs) and vaccines during pregnancy.

GSK Pregnancy Registries The Registry relies on voluntary reporting of pregnancy and exposures by women and health care providers (HCPs) who contact OTIS/MotherToBaby Pregnancy Studies, or the MotherToBaby network. The Registry is a research program and helps us gain further knowledge on use during pregnancy.

The Acyclovir Pregnancy Registry, established in 1984, and Pregnancy Registry, established in 1995, were completed in 1999. A final study is available to interested healthcare providers by calling the GlaxoSmithKline Customer Response Center at 1-888-825-5249 (toll-free).